B. Lenfant

发表

HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer.

P. Arnaud, C. Pontier, J. Pachot, 2001, Journal of pharmaceutical sciences.

Pharmacokinetics and Absolute Oral Bioavailability of an 800-mg Oral Dose of Telithromycin in Healthy Young and Elderly Volunteers

B. Lenfant, G. Montay, E. Sultan, 2002, Chemotherapy.

Pharmacokinetics of the New Ketolide Telithromycin (HMR 3647) Administered in Ascending Single and Multiple Doses

B. Lenfant, F. Namour, E. Sultan, 2001, Antimicrobial Agents and Chemotherapy.

Captopril/hydrochlorothiazide combination in elderly patients with mild-moderate hypertension. A double-blind, randomized, placebo-controlled study.

B. Lenfant, L. Baulac, C. Creisson, 1986, Postgraduate medical journal.

Recombinant human γ‐interferon in patients with chronic active hepatitis B: Pharmacokinetics, tolerance and biological effects

M. Loriot, P. Marcellin, C. Degott, 1990 .

Lack of Effect of Food on the Bioavailability of a New Ketolide Antibacterial, Telithromycin

B. Lenfant, G. Montay, E. Sultan, 2002, Scandinavian journal of infectious diseases.

Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: importance of drug ionisation in the in vitro prediction of in vivo absorption.

M. Boisset, J. Pachot, R. Botham, 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Concentrations of Cefpirome in Cerebrospinal Fluid of Children with Bacterial Meningitis after a Single Intravenous Dose

B. Lenfant, E. Sultan, K. Lehr, 1998, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers

B. Lenfant, A. Bryskier, F. Namour, 1995, Antimicrobial agents and chemotherapy.

Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteers.

J. Fourtillan, B. Lenfant, A. Bryskier, 1990, The Journal of antimicrobial chemotherapy.

Multiple dose pharmacokinetics of cefpodoxime in young adult and elderly patients.

B. Lenfant, C. Backhouse, D. Tremblay, 1990, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.

B. Lenfant, D. Tremblay, A. Dupront, 1990, The Journal of antimicrobial chemotherapy.

Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.

B. Lenfant, E. Sultan, J. Andrews, 1990, The Journal of antimicrobial chemotherapy.

Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.

P. Géhanno, B. Lenfant, E. Sultan, 1990, The Journal of antimicrobial chemotherapy.

Concentrations of cefpodoxime in plasma and lung tissue after a single oral dose of cefpodoxime proxetil.

L. Couraud, H. Lecoeur, B. Lenfant, 1990, The Journal of antimicrobial chemotherapy.

Trandolapril: Pharmacokinetics of Single Oral Doses in Healthy Male Volunteers

B. Lenfant, M. Mouren, D. Lauture, 1994, Journal of cardiovascular pharmacology.

Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children.

B. Lenfant, D. Kandiloros, P. Bégué, 1996, Journal of Antimicrobial Chemotherapy.

Recombinant human gamma-interferon in patients with chronic active hepatitis B: pharmacokinetics, tolerance and biological effects.

M. Loriot, P. Marcellin, C. Degott, 1990, Hepatology.

Penetration of telithromycin (HMR 3647), a new ketolide antimicrobial, into inflammatory blister fluid following oral administration.

B. Lenfant, F. Namour, E. Sultan, 2002, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and Pharmacodynamics of Trandolapril After Repeated Administration of 2 mg to Young and Elderly Patients with Mild‐to-Moderate Hypertension

P. Arner, B. Lenfant, P. Engfeldt, 1994, Journal of cardiovascular pharmacology.

Pharmacokinetics and Pharmacodynamics of Trandolapril After Repeated Administration of 2 mg to Patients with Chronic Renal Failure and Healthy Control Subjects

B. Lenfant, B. Danielson, E. Sultan, 1994, Journal of cardiovascular pharmacology.